{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:12:31Z","timestamp":1772691151228,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.medici.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,7,2]],"date-time":"2017-07-02T04:00:35Z","timestamp":1498968035000},"page":"179-189","source":"Crossref","is-referenced-by-count":10,"title":["The influence of oxazaphosphorine agents on kidney function in rats"],"prefix":"10.3390","volume":"53","author":[{"given":"\u0141ukasz","family":"Dobrek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Skowron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Baranowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaudia","family":"P\u0142oszaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"B\u0105dziul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Thor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","reference":[{"key":"10.1016\/j.medici.2017.05.004_bib0215","first-page":"970","article-title":"Drug-induced kidney diseases","volume":"51","author":"Singh","year":"2003","journal-title":"JAPI"},{"key":"10.1016\/j.medici.2017.05.004_bib0220","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MPH.0b013e3181f8cac0","article-title":"Nephrotoxicity \u2013 what do we know and what don\u2019t we know?","volume":"33","author":"Skinner","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.medici.2017.05.004_bib0225","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.02780312","article-title":"Onco-nephrology: renal toxicities of chemiotherapeutic agents","volume":"7","author":"Perazella","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medici.2017.05.004_bib0230","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","article-title":"Nephrotoxicity from chemiotherapeutic agents: clinical manifestations, pathobiology and prevention\/therapy","volume":"30","author":"Perazalla","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.medici.2017.05.004_bib0235","first-page":"247","article-title":"Nefrotoksyczno\u015b\u0107 pochodnych iperytu azotowego (ifosfamid, cyklofosfamid, trofosfamid) u dzieci","volume":"15","author":"Stefanowicz","year":"2011","journal-title":"Nefrol Dial Pol"},{"key":"10.1016\/j.medici.2017.05.004_bib0240","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00467-007-0689-6","article-title":"In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro","volume":"23","author":"Yaseen","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.medici.2017.05.004_bib0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.eururo.2008.05.007","article-title":"Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats","volume":"56","author":"Chuang","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.medici.2017.05.004_bib0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1464-4096.2004.04855.x","article-title":"Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders","volume":"94","author":"Dinis","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.medici.2017.05.004_bib0255","first-page":"171","article-title":"Effect of glutathione depletion on ifosfamide nephrotoxicity in rats","volume":"4","author":"Garimella-Krovi","year":"2008","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/j.medici.2017.05.004_bib0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-079X.2004.00131.x","article-title":"Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats","volume":"37","author":"Sener","year":"2004","journal-title":"J Pineal Res"},{"key":"10.1016\/j.medici.2017.05.004_bib0265","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/bjp.2008.15","article-title":"N-acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats","volume":"153","author":"Chen","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.medici.2017.05.004_bib0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jat.2550150510","article-title":"Nephrotoxicity of ifosfamide in rats","volume":"15","author":"Springate","year":"1995","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.medici.2017.05.004_bib0275","first-page":"805","article-title":"Urinary kidney injury molecule-1 (KIM-1) excretion in rats experimental cystitis induced by oxazaphosphorines","volume":"73","author":"Dobrek","year":"2016","journal-title":"Przegl Lek"},{"key":"10.1016\/j.medici.2017.05.004_bib0280","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1681\/ASN.V1281615","article-title":"Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide","volume":"12","author":"Dubourg","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.medici.2017.05.004_bib0285","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/mp100329u","article-title":"New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2","volume":"8","author":"Ciarimboli","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.medici.2017.05.004_bib0290","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: biopharmaceutical, physiological and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.medici.2017.05.004_bib0295","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.10.2011.4950","article-title":"Ifosfamide induced Fanconi syndrome","author":"Buttemer","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.medici.2017.05.004_bib0300","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bju.12291","article-title":"Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges","volume":"112","author":"Payne","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.medici.2017.05.004_bib0305","first-page":"737","article-title":"A review on renal protective agents for cyclophosphamide induced nephrotoxicity","volume":"3","author":"Singh","year":"2014","journal-title":"WJPPS"},{"key":"10.1016\/j.medici.2017.05.004_bib0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.etp.2007.05.003","article-title":"Effect of cyclophosphamide treatment on selected lysosomal enzymes in the kidney of rats","volume":"59","author":"Abraham","year":"2007","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.medici.2017.05.004_bib0315","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1097\/01.ASN.0000023430.92674.E5","article-title":"Renal tubular acidosis: the clinical entity","volume":"13","author":"Soriano","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.medici.2017.05.004_bib0320","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12098-007-0120-0","article-title":"Evaluation of renal tubular acidosis","volume":"74","author":"Bagga","year":"2007","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.medici.2017.05.004_bib0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5049\/EBP.2011.9.1.7","article-title":"The role of proximal nephron in cyclophosphamide-induced water retention: preliminary data","volume":"9","author":"Kim","year":"2011","journal-title":"Electrolyte Blood Press"},{"key":"10.1016\/j.medici.2017.05.004_bib0330","doi-asserted-by":"crossref","first-page":"F474","DOI":"10.1152\/ajprenal.00477.2014","article-title":"Cyclophosphamide-induced vasopressin-independent activation of aquaporin-2 in the rat kidney","volume":"309","author":"Kim","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.medici.2017.05.004_bib0335","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI200422353","article-title":"Acute renal failure: definitions, diagnosis, pathogenesis, and therapy","volume":"114","author":"Schrier","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.medici.2017.05.004_bib0340","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cphy.c110041","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Compr Physiol"},{"key":"10.1016\/j.medici.2017.05.004_bib0345","first-page":"155","article-title":"Acute kidney injury: the modern therapeutic approach","volume":"4","author":"Hurtarte-Sandoval","year":"2014","journal-title":"Surg Curr Res"},{"key":"10.1016\/j.medici.2017.05.004_bib0350","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/hepr.12068","article-title":"Relationship between urinary fractional excretion of sodium and life prognosis in liver cirrhosis patients","volume":"43","author":"Ohashi","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.medici.2017.05.004_bib0355","first-page":"1519","article-title":"Neutrophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine","volume":"50","author":"Makris","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.medici.2017.05.004_bib0360","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2008.01.020","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage","volume":"52","author":"Bolignano","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.medici.2017.05.004_bib0365","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1515\/cclm-2011-0814","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences","volume":"50","author":"Clerico","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.medici.2017.05.004_bib0370","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/ijc.22352","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition","volume":"120","author":"Lim","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.medici.2017.05.004_bib0375","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1515\/cclm-2012-0307","article-title":"Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review","volume":"50","author":"Cruz","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.medici.2017.05.004_bib0380","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","article-title":"Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans","volume":"53","author":"Wang","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.medici.2017.05.004_bib0385","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1159\/000368474","article-title":"Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases \u2013 review","volume":"39","author":"Helanova","year":"2014","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.medici.2017.05.004_bib0390","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semnephrol.2009.03.008","article-title":"The physiology of urinary concentration: an update","volume":"29","author":"Sands","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.medici.2017.05.004_bib0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/0300-1652.104376","article-title":"The renal concentrating mechanism and the clinical consequences of its loss","volume":"53","author":"Agaba","year":"2012","journal-title":"Niger Med J"},{"key":"10.1016\/j.medici.2017.05.004_bib0400","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.medici.2017.05.004_bib0405","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in human against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.medici.2017.05.004_bib0410","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/abbi.2000.1721","article-title":"Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid","volume":"376","author":"Squadrito","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.medici.2017.05.004_bib0415","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1749-6632.2002.tb04072.x","article-title":"A reassessment of the peroxynitrite scavenging activity of uric acid","volume":"962","author":"Whiteman","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.medici.2017.05.004_bib0420","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jfma.2013.06.004","article-title":"Hemorrhagic cystitis in children treated with alkylating agent cyclophosphamide: the experience of a medical center in Taiwan","volume":"114","author":"Wang","year":"2015","journal-title":"J Formos Med Assoc"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X17300381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X17300381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T05:14:46Z","timestamp":1719292486000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010660X17300381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"alternative-id":["S1010660X17300381"],"URL":"https:\/\/doi.org\/10.1016\/j.medici.2017.05.004","relation":{},"ISSN":["1010-660X"],"issn-type":[{"value":"1010-660X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}